Alcidion Group

Alcidion Group Capital Intensity

The Capital Intensity Ratio of Alcidion Group (ALC.AX) as of Nov 11, 2026 is 236.01 %. In the previous year, Capital Intensity Ratio was 283.49 % — a change of -16.75% (lower).

Capital Intensity

236.01 %

YoY

-16.75%

Last updated:

Capital Intensity Ratio of Alcidion Group is 2026 236.01 % . Capital Intensity Ratio of Alcidion Group was 2025 283.49 % . It decreases by -16.75% lower compared to the previous year.

The Alcidion Group Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2019
147.40 AUD
Jan 1, 2020
212.57 AUD
Jan 1, 2021
225.58 AUD
Jan 1, 2022
373.61 AUD
Jan 1, 2023
298.72 AUD
Jan 1, 2024
308.88 AUD
Jan 1, 2025
283.49 AUD
Jan 1, 2026
236.01 AUD
The Alcidion Group Capital Intensity history
YEARCapital IntensityYoY
236.01 %-16.75%
283.49 %-8.22%
308.88 %+3.40%
298.72 %-20.04%
373.61 %+65.62%
225.58 %+6.12%
212.57 %+44.22%
147.40 %+5.66%
139.50 %-29.38%
197.54 %-1.44%
200.44 %+175.97%
72.63 %-57.46%
170.73 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alcidion Group Stock analysis

What does Alcidion Group do? Alcidion Group Ltd. generates revenue through the development and licensing of its healthcare software products, including Miya Precision, Miya Observations, Flow, Task Management, and PAS, marketed under the Miya brand. The company also resells selected healthcare software from strategic partners and provides implementation, support, maintenance, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product Miya Precision, a FHIR-event platform-based solution, supports clinical and operational applications, while Smartpage offers hospital communication and task management via smartphone and web. The firm serves over 400 hospitals across its key markets. Miya Precision and its associated modules form the core of Alcidion's product portfolio, targeting hospitals seeking integrated clinical solutions. Smartpage, Patientrack, and Silverlink PCS complement these offerings, catering to diverse healthcare communication and operational needs. The company’s revenue streams are driven by direct sales of software licenses, ongoing service contracts, and partner resales, with a focus on the Australian, New Zealand, and UK healthcare sectors. Alcidion’s business model emphasizes software licensing and service delivery, with Miya Precision as the primary revenue generator. The company’s strategic partnerships enable it to resell third-party software, expanding its product range without additional development costs. Healthcare institutions in Australia, New Zealand, and the United Kingdom are the primary buyers, leveraging Alcidion’s solutions for improved clinical workflows and operational efficiency. Alcidion Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcidion Group stock

Capital Intensity Ratio of Alcidion Group is 236.01 % in 2026.

Capital Intensity Ratio of Alcidion Group changed from 283.49 % to 236.01 %, representing a -16.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Alcidion Group since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Alcidion Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Alcidion Group

All Key Metrics — Alcidion Group